Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Ramat Gan, Israel
SEC filing record 1 source field available
Fiscal year end
31 December
Galmed Pharmaceuticals Ltd. has filed 364 SEC EDGAR filings since 31 Dec 2013

SEC filing history

Showing 1-25 of 213 matching filings.

Per page
25
Current page
1
6-K File 001-36345

6-K

Filing date
22 Jun 2026
Reporting date
22 Jun 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36345

6-K

Filing date
08 Jun 2026
Reporting date
08 Jun 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36345

6-K

Filing date
02 Jun 2026
Reporting date
02 Jun 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36345

6-K

Filing date
14 May 2026
Reporting date
14 May 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36345

6-K

Filing date
06 May 2026
Reporting date
06 May 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36345

6-K

Filing date
14 Apr 2026
Reporting date
14 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36345

6-K

Filing date
09 Apr 2026
Reporting date
09 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36345

6-K

Filing date
05 Mar 2026
Reporting date
05 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36345

6-K

Filing date
04 Mar 2026
Reporting date
04 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36345

6-K

Filing date
09 Feb 2026
Reporting date
09 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36345

6-K

Filing date
30 Jan 2026
Reporting date
30 Jan 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36345

6-K

Filing date
08 Dec 2025
Reporting date
08 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36345

6-K

Filing date
04 Dec 2025
Reporting date
04 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36345

6-K

Filing date
01 Dec 2025
Reporting date
01 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36345

6-K

Filing date
18 Nov 2025
Reporting date
18 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36345

6-K

Filing date
17 Nov 2025
Reporting date
17 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36345

6-K

Filing date
29 Oct 2025
Reporting date
29 Oct 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36345

6-K

Filing date
28 Oct 2025
Reporting date
28 Oct 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36345

6-K

Filing date
19 Sep 2025
Reporting date
19 Sep 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36345

6-K

Filing date
25 Aug 2025
Reporting date
25 Aug 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36345

6-K

Filing date
15 Aug 2025
Reporting date
15 Aug 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36345

6-K

Filing date
14 Aug 2025
Reporting date
14 Aug 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36345

6-K

Filing date
24 Jul 2025
Reporting date
24 Jul 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .